Breast Imaging Fellowship
The Breast Imaging Section at Yale offers a comprehensive fellowship according to the guidelines and curriculum recommended by the Society of Breast Imaging. The faculty members are leaders in the fields of digital breast tomosynthesis and screening breast ultrasound. Our fellows receive extensive clinical exposure to all aspects of breast imaging including cutting edge technology such as digital breast tomosynthesis and 3T breast MRI. The fellows are also well trained in the fundamentals of breast imaging including screening and diagnostic mammography, ultrasonography and interventional breast procedures. Currently, two twelve-month fellowship positions are offered annually. All twelve-month breast imaging fellows are offered one month of elective time. For those trainees interested in research, numerous projects are available.
The Breast Imaging section performs more than 50,000 studies each year. More than 15,000 screening mammograms with tomosynthesis are performed at Yale New Haven Hospital, Bridgeport Hospital Outpatient facilities, and multiple satellite offices. In addition, more than 5,000 diagnostic mammograms, as well as ductograms, breast ultrasound and breast MRI exams are performed annually. More than 1,000 interventional procedures are performed each year and include mammographic, sonographic, and MRI guided needle localizations and stereotactic, sonographic, and MRI- guided core biopsies.
Bi-weekly (fortnightly) lectures are provided by the breast imaging faculty. In addition, monthly interdisciplinary conferences take place with lectures provided by faculty in breast imaging, breast surgery, oncology and pathology. Bi-weekly interesting case conferences as well as journal clubs provide additional opportunities for education. Each week, one trainee (fellow or mini-fellow) prepares cases for tumor board and presents these while supervised by an attending radiologist.
Breast Imaging FacultyJohn Lewin, MD Division Chief
Liva Andrejeva-Wright, MD Fellowship Director
Reni Butler, MD
Melissa Durand, MD
Maryam Etsami, MD
Regina Hooley, MD
Thomas Young, MD
Bhumika Patel, MD
Applying For Fellowship:
Application will be accepted beginning August 1, 2022 for the 2024-2025 academic year, (July 1, 2024 – June 30, 2025).
We Participate in the National Residency Matching Program (NRMP)
Applications must be submitted and complete by November 1, 2022. Candidates selected for an interview will be contacted via e-mail.Please note that, in accordance with Society of Breast Imaging recommendations, no formal interviews will be conducted before November 1, 2022.
How to Apply
You must submit your application through the following secure portal. Do not submit your application materials directly to us via email.
The information & documents (please upload PDFs) requested through the portal includes:
- Curriculum Vitae
- Personal Statement - Please limit the personal statement to one page: double spaced and 12 point font Times New Roman.
- UNIVERSAL APPLICATION
- Medical School Transcripts or Dean’s Letter
- 3 letters of recommendation (signed and on official letterhead): One letter must be from the residency program director
- A photograph is requested but not required.
- USMLE Steps I, II and III score
- ECFMG Certificate, if applicable
- Candidates should be eligible or certified by the American Board of Radiology.
- Hold or be eligible for a permanent medical license in Connecticut.
- Must have evidence of valid work authorization.
- Being authorized to work in the United States is a precondition of employment in this Breast Imaging Fellowship Program.
- The fellowship program and the department of Radiology and Biomedical Imaging are unable to sponsor applicants requiring a work visa.
Liva Andrejeva, MD
E-mail (preferred):Serena DelBasso
Yale School of Medicine
Department of Radiology and Biomedical Imaging
Breast Imaging Fellowship Program
P.O. Box 208042
333 Cedar Street
New Haven, CT 06520-8042
The video below shows a 56 year old woman with multiple spiculated masses seen on tomosynthesis. Core needle biopsy revealed infiltrating ductal carcinoma.